- $1.19bn
- $1.76bn
- $712.88m
- 57
- 63
- 38
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 469 | 35.1 | 443 | 600 | 713 |
Cost of Revenue | |||||
Gross Profit | 363 | 10.4 | 352 | 460 | 531 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 481 | 752 | 402 | 526 | 632 |
Operating Profit | -12.4 | -717 | 40.7 | 73.8 | 81.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -53.8 | -774 | -18.8 | 69.2 | 70.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -53.8 | -774 | -19.1 | 70.8 | 113 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -53.8 | -774 | -16.1 | 28.7 | 74.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -53.8 | -774 | -3.28 | 70.8 | 74.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.264 | -1.02 | 0.258 | 0.395 | 0.419 |
Dividends per Share |